Use of Selenium in GO Over the last few years, in addition to the most common treatment for the management of moderate-to-severe and active GO, namely high dose oral and intravenous glucocorticoids (GC), orbital irradiation and surgical procedures (58), other medications have been proven effective to various extents, including rituximab (59), the recently FDA-approved teprotumumab (60, 61), mycophenolate (62), and tocilizumab (63)
This also allows for higher dosages to be used safely compared to oral supplementation
Participants included 57 children diagnosed with Autistic Spectrum Disorder (3-7 years old
While riboflavin may not be a panacea for everyone with migraines, it is inexpensive, non-toxic, safe, and effective for some migraine sufferers
It exerts systemic effects, benefiting organs and tissues throughout the body
Ferroptosis: a new regulatory mechanism in osteoporosis